{
    "2018-04-06": [
        [
            {
                "time": "2018-01-02",
                "original_text": "NJ Man Wins $37 Million in J&J Baby Powder Case",
                "features": {
                    "keywords": [
                        "J&J",
                        "Baby Powder",
                        "trial",
                        "cancer",
                        "talc"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-03",
                "original_text": "Stocks dive as US proposes more China tariffs; Dow falls 620",
                "features": {
                    "keywords": [
                        "tariffs",
                        "China",
                        "Dow",
                        "stocks",
                        "dive"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "global trade"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-05",
                "original_text": "Stocks skid again after US proposes more China tariffs",
                "features": {
                    "keywords": [
                        "tariffs",
                        "China",
                        "stocks",
                        "skid"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "global trade"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-09",
                "original_text": "The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Johnson & Johnson",
                "features": {
                    "keywords": [
                        "class action",
                        "lawsuit",
                        "Johnson & Johnson"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "The Zacks Analyst Blog Highlights: Tandem Diabetes Care, Addus HomeCare, Tailored Brands, Tellurian and Johnson & Johnson",
                "features": {
                    "keywords": [
                        "Zacks",
                        "analyst",
                        "Tandem Diabetes Care",
                        "Addus HomeCare",
                        "Tailored Brands",
                        "Tellurian",
                        "Johnson & Johnson"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "retail",
                        "energy"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-11",
                "original_text": "4 Drug/Biotech Stocks to Buy Ahead of World Health Day",
                "features": {
                    "keywords": [
                        "Drug",
                        "Biotech",
                        "World Health Day"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-12",
                "original_text": "MARKETS: Watch out for the 'Kudlow Put' round 2 and the Chinese tariff tantrum",
                "features": {
                    "keywords": [
                        "Kudlow Put",
                        "Chinese tariff",
                        "tantrum"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "global trade"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-13",
                "original_text": "The Top 5 Johnson & Johnson Shareholders (JNJ)",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "shareholders"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-14",
                "original_text": "Can Been-There Biotech Entrepreneur Arie Belldegrun Do It Yet Again?",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Arie Belldegrun"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-15",
                "original_text": "These Alphabet-Backed Biotech Startups Went Public In 1Q18",
                "features": {
                    "keywords": [
                        "Alphabet",
                        "Biotech",
                        "startups",
                        "public"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-16",
                "original_text": "JNJ EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Johnson & Johnson",
                "features": {
                    "keywords": [
                        "JNJ",
                        "Equity Alert",
                        "class action",
                        "Johnson & Johnson"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-17",
                "original_text": "3 Emerging Technologies Set to Transform the Pharma World",
                "features": {
                    "keywords": [
                        "Emerging Technologies",
                        "Pharma"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-18",
                "original_text": "J&J, Imerys Ordered To Pay $37 Mln In Case Over Talc Cancer Risks",
                "features": {
                    "keywords": [
                        "J&J",
                        "Imerys",
                        "talc",
                        "cancer",
                        "risks"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-19",
                "original_text": "J&J loses trial over claims linking cancer to asbestos in talc",
                "features": {
                    "keywords": [
                        "J&J",
                        "trial",
                        "cancer",
                        "asbestos",
                        "talc"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}